Applying new biotechnologies to the study of occupational cancer--a workshop summary.
As high-throughput technologies in genomics, transcriptomics, and proteomics evolve, questions arise about their use in the assessment of occupational cancers. To address these questions, the National Institute for Occupational Safety and Health, the National Cancer Institute, the National Institute of Environmental Health Sciences, and the American Chemistry Council sponsored a workshop 8-9 May 2002 in Washington, DC. The workshop brought together 80 international specialists whose objective was to identify the means for best exploiting new technologies to enhance methods for laboratory investigation, epidemiologic evaluation, risk assessment, and prevention of occupational cancer. The workshop focused on identifying and interpreting markers for early biologic effect and inherited modifiers of risk.
Toraason
Mark
M
National Institute for Occupational Safety and Health, 4676 Columbia Parkway, Cincinnati, OH 45226, USA. mtoraason@cdc.gov
Albertini
Richard
R
Bayard
Steven
S
Bigbee
William
W
Blair
Aaron
A
Boffetta
Paolo
P
Bonassi
Stefano
S
Chanock
Steven
S
Christiani
David
D
Eastmond
David
D
Hanash
Samuel
S
Henry
Carol
C
Kadlubar
Fred
F
Mirer
Frank
F
Nebert
Daniel
D
Rapport
Stephen
S
Rest
Kathleen
K
Rothman
Nathaniel
N
Ruder
Avima
A
Savage
Russell
R
Schulte
Paul
P
Siemiatycki
Jack
J
Shields
Peter
P
Smith
Martyn
M
Tolbert
Paige
P
Vermeulen
Roel
R
Vineis
Paolo
P
Wacholder
Sholom
S
Ward
Elizabeth
E
Waters
Michael
M
Weston
Ainsley
A
D015415:Biomarkers / Q000032:analysis; D004777:Environment; D015386:Hazardous Substances / Q000506:poisoning; D006801:Humans; D009369:Neoplasms / Q000209:etiology*; D016273:Occupational Exposure; D011110:Polymorphism, Genetic; D018570:Risk Assessment; D012307:Risk Factors; D043922:Toxicogenetics / Q000639:trends*
D015415:Biomarkers; D015386:Hazardous Substances